Could you please tell me about the valuation of the latest round of financing of the companies in which the company has a stake?

Neusoft Group: Hello, according to the company's previous disclosure, the post-investment valuation of Neusoft Medical in September 2017 was over 4.7 billion yuan, the post-investment valuation of Xikang in the end of 2019 was approximately 3.9 billion yuan, and the post-investment valuation of Wanghai in the end of 2017 was approximately 4.6 billion yuan.